Effects of etelcalcetide and cinacalcet for the vascular carcification in hemodialysis patients with secondary hyperparathyroidism

Trial Profile

Effects of etelcalcetide and cinacalcet for the vascular carcification in hemodialysis patients with secondary hyperparathyroidism

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Cinacalcet (Primary) ; Etelcalcetide (Primary)
  • Indications Secondary hyperparathyroidism
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top